Addressing Challenges And Key Considerations For Comparator Sourcing In And To China

Comparator sourcing is crucial for ensuring the integrity of clinical trials, but it’s undeniably complex — especially when it takes place overseas. In recent years, the Chinese government has accelerated clinical approvals for both small molecule therapeutics and biologics. This recent rise of approvals, paired with a large and growing network of qualified hospitals to conduct clinical trials, is enabling sponsors to conduct more trials in the region.

However, navigating the complexity of comparator sourcing is essential to reduce risk of delays and optimize clinical trial design. Sponsors must meet the strict and high-quality standards of the country, overcome payment solution hurdles for foreign companies, and ensure stable drug supply.

Utilizing multi-channel sourcing strategies to respond to supply shortages and leveraging the experience and knowledge of an outsourcing partner can help to overcome the challenges of local and global comparator sourcing. Watch our on-demand webinar to explore approaches to overcome the various challenges of comparator sourcing in and to China. The webinar covers a variety of relevant topics, including how to:

• Build a bridge between obstacles and solutions for comparator sourcing,
• Address concerns when establishing a commercial materials supply chain,
• Reduce risk and costs with a strategic approach to sourcing comparators,
• Make it all work, with a look at case studies and success story examples.